These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 23271773)
21. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions. Loeb S; Zhou Q; Siebert U; Rochau U; Jahn B; Mühlberger N; Carter HB; Lepor H; Braithwaite RS Eur Urol; 2017 Dec; 72(6):899-907. PubMed ID: 28844371 [TBL] [Abstract][Full Text] [Related]
22. Contingent Knowledge and Looping Effects - A 66-Year-Old Man with PSA-Detected Prostate Cancer and Regrets. Aronowitz R; Greene JA N Engl J Med; 2019 Sep; 381(12):1093-1096. PubMed ID: 31532956 [No Abstract] [Full Text] [Related]
23. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance. Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791 [TBL] [Abstract][Full Text] [Related]
24. Understanding Advanced Prostate Cancer Decision Making Utilizing an Interactive Decision Aid. Jones RA; Hollen PJ; Wenzel J; Weiss G; Song D; Sims T; Petroni G Cancer Nurs; 2018; 41(1):2-10. PubMed ID: 27811543 [TBL] [Abstract][Full Text] [Related]
25. How do patients choose between active surveillance, radical prostatectomy, and radiotherapy? The effect of a preference-sensitive decision aid on treatment decision making for localized prostate cancer. Lamers RE; Cuypers M; de Vries M; van de Poll-Franse LV; Ruud Bosch JL; Kil PJ Urol Oncol; 2017 Feb; 35(2):37.e9-37.e17. PubMed ID: 28341494 [TBL] [Abstract][Full Text] [Related]
26. Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy. Roussel B; Ouellet GM; Mohile SG; Dale W Clin Geriatr Med; 2015 Nov; 31(4):615-29. PubMed ID: 26476120 [TBL] [Abstract][Full Text] [Related]
27. Decision aid use during post-biopsy consultations for localized prostate cancer. Holmes-Rovner M; Srikanth A; Henry SG; Langford A; Rovner DR; Fagerlin A Health Expect; 2018 Feb; 21(1):279-287. PubMed ID: 28881105 [TBL] [Abstract][Full Text] [Related]
28. A longitudinal study of changes in provider-patient interaction in treatment of localized prostate cancer. Ernstmann N; Ommen O; Kowalski C; Neumann M; Visser A; Pfaff H; Weissbach L Support Care Cancer; 2012 Apr; 20(4):791-7. PubMed ID: 21479989 [TBL] [Abstract][Full Text] [Related]
30. Evaluating a decision aid for patients with localized prostate cancer in clinical practice. Isebaert S; Van Audenhove C; Haustermans K; Junius S; Joniau S; De Ridder K; Van Poppel H Urol Int; 2008; 81(4):383-8. PubMed ID: 19077396 [TBL] [Abstract][Full Text] [Related]
31. Head to head randomized trial of two decision aids for prostate cancer. Fagerlin A; Holmes-Rovner M; Hofer TP; Rovner D; Alexander SC; Knight SJ; Ling BS; A Tulsky J; Wei JT; Hafez K; Kahn VC; Connochie D; Gingrich J; Ubel PA BMC Med Inform Decis Mak; 2021 May; 21(1):154. PubMed ID: 33980208 [TBL] [Abstract][Full Text] [Related]
32. [Elderly prostate cancer patients: patient information and shared decision making]. Ernstmann N; Jaeger J; Kowalski C; Pfaff H; Weißbach L Urologe A; 2013 Jun; 52(6):847-52. PubMed ID: 23328778 [TBL] [Abstract][Full Text] [Related]
33. Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study. Brooks JV; Ellis SD; Morrow E; Kimminau KS; Thrasher JB Am J Mens Health; 2018 Sep; 12(5):1719-1727. PubMed ID: 29973123 [TBL] [Abstract][Full Text] [Related]
34. Treatment decisions for localized prostate cancer: a concept mapping approach. McFall SL; Mullen PD; Byrd TL; Cantor SB; Le YC; Torres-Vigil I; Pettaway C; Volk RJ Health Expect; 2015 Dec; 18(6):2079-90. PubMed ID: 24506829 [TBL] [Abstract][Full Text] [Related]
35. The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer. Wilt TJ J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):184-90. PubMed ID: 23271771 [TBL] [Abstract][Full Text] [Related]
36. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study. Myers RE; Leader AE; Censits JH; Trabulsi EJ; Keith SW; Petrich AM; Quinn AM; Den RB; Hurwitz MD; Lallas CD; Hegarty SE; Dicker AP; Zeigler-Johnson CM; Giri VN; Ayaz H; Gomella LG J Cancer Educ; 2018 Feb; 33(1):180-185. PubMed ID: 27418065 [TBL] [Abstract][Full Text] [Related]
37. An evidence review of active surveillance in men with localized prostate cancer. Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653 [TBL] [Abstract][Full Text] [Related]
38. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer. Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777 [TBL] [Abstract][Full Text] [Related]
39. The experience of adults who choose watchful waiting or active surveillance as an approach to medical treatment: a qualitative systematic review. Rittenmeyer L; Huffman D; Alagna M; Moore E JBI Database System Rev Implement Rep; 2016 Feb; 14(2):174-255. PubMed ID: 27536798 [TBL] [Abstract][Full Text] [Related]
40. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Davison BJ; Breckon E Patient Educ Couns; 2012 Jun; 87(3):369-74. PubMed ID: 22177658 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]